Literature DB >> 11325466

Expression of canine interferon-gamma by a recombinant vaccinia virus and its antiviral effect.

Y Nishikawa1, A Iwata, A Katsumata, X Xuan, H Nagasawa, I Igarashi, K Fujisaki, H Otsuka, T Mikami.   

Abstract

A recombinant vaccinia virus-expressing canine interferon (IFN)-gamma (vv/cIFN-gamma) was constructed. In rabbit kidney (RK13) and canine A72 cells infected with vv/cIFN-gamma, IFN activity was detected in the culture supernatants of both cell types. Canine IFN-gamma was also detected in both cell extracts by Western blot. The activity of the recombinant canine IFN-gamma in RK13 cells was higher than that in A72 cells. The vv/cIFN-gamma could not grow in A72 cells at a low multiplicity of infection, probably due to the antiviral activity of the canine IFN-gamma produced. Although exogenous IFN-gamma did not inhibit the growth of vaccinia virus, addition of anti-canine IFN-gamma serum recovered the growth of the vv/cIFN-gamma on A72 cells in a dose-dependent manner. These results suggest that the growth of vv/cIFN-gamma was inhibited by IFN-gamma produced in a paracrine and autocrine manner. In addition, the recombinant canine IFN-gamma inhibited the multiplication of canine herpesvirus, pseudorabies virus and canine adenovirus type 1 in Madin-Darby canine kidney cells. The antiviral effect of canine IFN-gamma was more effective than that of canine IFN-beta. From the present studies, we concluded the recombinant virus may be a useful suicide viral vector.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325466     DOI: 10.1016/s0168-1702(01)00223-4

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  1 in total

1.  Expression and characterization of bovine lactoperoxidase by recombinant vaccinia virus.

Authors:  Tetsuya Tanaka; Xuenan Xuan; Asato Kojima; Ikuo Igarashi; Kozo Fujisaki; Kei-Ichi Shimazaki
Journal:  Cytotechnology       Date:  2009-02-12       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.